Myriad Genetics (MYGN) Tops Q4 EPS by 5c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Myriad Genetics (MYGN) PT Raised to $52 at Stephens
August 22, 2018 6:12 AM EDTStephens analyst Drew Jones raised the price target on Myriad Genetics (NASDAQ: MYGN) to $52.00 (from $45.00) while maintaining a Overweight rating.
... MoreMyriad Genetics (MYGN) PT Raised to $38 at Piper Jaffray
August 22, 2018 6:01 AM EDTPiper Jaffray analyst William Quirk raised the price target on Myriad Genetics (NASDAQ: MYGN) to $38.00 (from $32.00) while maintaining a Neutral rating.
... More


